Zealand Pharma A/S - Laporan Laba Rugi (TTM)

Zealand Pharma A/S
US ˙ OTCPK ˙ DK0060257814

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Zealand Pharma A/S menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 301 192 347 161 158 109 114 104 93 104 107 92 343 343 344 368 77 63 56 9,110
Change (%) -36.31 80.52 -53.60 -1.45 -31.50 4.84 -8.64 -10.07 11.22 2.57 -14.05 274.67 -0.20 0.43 6.89 -79.11 -18.45 -11.16 16,256.96
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 62 91 74 39 11 11 -0 0 -12 -9 3 8 30 19 8 4 -5
Change (%) -18.76 -46.67 -72.04 0.00 -100.64 -100.00 -30.14 -137.29 143.88 279.16 -34.92 -59.05 -53.24 -246.58
% of Revenue 20.67 26.13 45.76 24.76 10.11 9.64 -0.07 0.00 -13.38 -2.49 0.93 2.26 8.03 25.01 12.56 6.61 -0.06
Gross Operating Profit 239 192 256 87 119 98 103 104 93 104 107 104 352 340 336 338 58 55 52 9,115
Change (%) -19.72 33.35 -65.93 36.69 -18.16 5.38 1.17 -10.13 11.22 2.57 -2.55 238.71 -3.54 -0.92 0.59 -82.97 -4.90 -5.12 17,425.27
% of Revenue 79.33 100.00 73.87 54.24 75.24 89.89 90.36 100.07 100.00 100.00 100.00 113.38 102.49 99.07 97.74 91.97 74.99 87.44 93.39 100.06
SG&A 300 222 575 480 416 298 231 286 273 258 241 215 205 216 244 270 314 404 431 461
Change (%) -25.92 158.43 -16.42 -13.46 -28.26 -22.43 23.67 -4.61 -5.36 -6.82 -10.55 -4.86 5.44 13.10 10.40 16.36 28.78 6.79 6.87
% of Revenue 99.58 115.83 165.82 298.70 262.32 274.73 203.27 275.16 291.87 248.37 225.62 234.79 59.62 62.99 70.94 73.27 408.13 644.47 774.69 5.06
R&D 612 596 574 595 595 582 602 606 612 614 601 605 656 685 734 790 856 920 1,019 1,272
Change (%) -2.59 -3.58 3.53 0.02 -2.25 3.52 0.68 1.02 0.29 -2.16 0.70 8.47 4.37 7.11 7.63 8.44 7.44 10.80 24.79
% of Revenue 202.91 310.34 165.75 369.86 375.39 535.73 529.01 582.96 654.90 590.51 563.26 659.90 191.05 199.80 213.09 214.56 1,113.74 1,467.30 1,830.09 13.96
OpEx 973 818 1,239 1,148 1,050 891 845 893 886 921 883 856 901 904 993 1,089 1,192 1,332 1,476 1,924
Change (%) -15.91 51.43 -7.31 -8.60 -15.14 -5.18 5.69 -0.76 3.93 -4.12 -2.99 5.19 0.38 9.80 9.67 9.52 11.70 10.83 30.36
% of Revenue 322.80 426.16 357.48 714.17 662.36 820.56 742.14 858.52 947.43 885.30 827.52 933.97 262.21 263.73 288.35 295.86 1,551.03 2,124.33 2,650.13 21.12
Operating Income -672 -626 -892 -988 -891 -782 -731 -789 -792 -817 -776 -765 -557 -561 -648 -721 -1,115 -1,269 -1,420 7,186
Change (%) -6.76 42.51 10.67 -9.77 -12.23 -6.57 7.92 0.47 3.07 -4.98 -1.47 -27.12 0.73 15.53 11.15 54.76 13.78 11.91 -605.95
% of Revenue -222.80 -326.16 -257.48 -614.17 -562.36 -720.56 -642.14 -758.52 -847.43 -785.30 -727.52 -833.97 -162.21 -163.73 -188.35 -195.86 -1,451.03 -2,024.33 -2,550.13 78.88
Interest Expense -22 -49 -4 -3 -3 -4 -20 -27 -34 -58 -50 -53 -44 -26 -21 -21 -29 -34 -35 -32
Change (%) 120.62 -92.06 -18.93 5.96 21.68 393.28 31.78 29.60 67.67 -13.21 5.31 -17.11 -41.01 -19.36 2.91 34.87 17.77 4.25 -9.71
% of Revenue -7.41 -25.68 -1.13 -1.97 -2.12 -3.77 -17.73 -25.58 -36.87 -55.58 -47.03 -57.62 -12.75 -7.54 -6.05 -5.83 -37.61 -54.31 -63.73 -0.35
Net Income -660 -847 -909 -1,148 -1,118 -1,018 -999 -1,190 -1,140 -1,202 -1,173 -1,004 -781 -704 -739 -712 -1,053 -1,079 -1,186 6,681
Change (%) 28.32 7.40 26.25 -2.59 -8.97 -1.90 19.19 -4.25 5.46 -2.43 -14.41 -22.16 -9.94 4.98 -3.62 47.83 2.50 9.89 -663.54
% of Revenue -218.89 -441.00 -262.38 -713.97 -705.77 -937.99 -877.70 -1,145.07 -1,219.29 -1,156.05 -1,099.71 -1,095.09 -227.51 -205.30 -214.60 -193.49 -1,369.25 -1,720.87 -2,128.64 73.34

Source: Capital IQ

Other Listings
DK:ZEAL DKK 449.40
GB:0NZU
GB:ZEALC
DE:22Z € 61.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista